You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Cognitive Effects of Long-Term Benzodiazepine Use
|
|---|---|
| Published in |
CNS Drugs, August 2012
|
| DOI | 10.2165/00023210-200418010-00004 |
| Pubmed ID | |
| Authors |
Melinda J. Barker, Kenneth M. Greenwood, Martin Jackson, Simon F. Crowe |
| Abstract |
While benzodiazepines are the most widely used psychotropic drugs, there are relatively few studies that have examined deficits in cognitive functioning after long-term use. The literature that is available is difficult to interpret due to conflicting results as well as a variety of methodological flaws. |
X Demographics
The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 33% |
| United Kingdom | 1 | 11% |
| Chile | 1 | 11% |
| Canada | 1 | 11% |
| Unknown | 3 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 56% |
| Practitioners (doctors, other healthcare professionals) | 2 | 22% |
| Scientists | 2 | 22% |
Mendeley readers
The data shown below were compiled from readership statistics for 332 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | <1% |
| Colombia | 1 | <1% |
| Netherlands | 1 | <1% |
| France | 1 | <1% |
| Portugal | 1 | <1% |
| Canada | 1 | <1% |
| United Kingdom | 1 | <1% |
| Japan | 1 | <1% |
| Argentina | 1 | <1% |
| Other | 0 | 0% |
| Unknown | 322 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 52 | 16% |
| Student > Master | 49 | 15% |
| Student > Ph. D. Student | 35 | 11% |
| Student > Bachelor | 27 | 8% |
| Other | 25 | 8% |
| Other | 77 | 23% |
| Unknown | 67 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 108 | 33% |
| Psychology | 61 | 18% |
| Neuroscience | 25 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 16 | 5% |
| Agricultural and Biological Sciences | 12 | 4% |
| Other | 27 | 8% |
| Unknown | 83 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 328. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 May 2023.
All research outputs
#103,358
of 25,837,817 outputs
Outputs from CNS Drugs
#3
of 1,403 outputs
Outputs of similar age
#432
of 191,537 outputs
Outputs of similar age from CNS Drugs
#1
of 547 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,403 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.0. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 191,537 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 547 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.